Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya

January 19, 2024

https://www.globenewswire.com/news-release/2023/12/27/2801366/8624/en/Trinity-Biotech-Announces-It-Has-Begun-Shipments-of-Its-New-HIV-Screening-Test-TrinScreen-HIV-to-Kenya.html

DUBLIN, Ireland, Dec. 27, 2023 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq:TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announces it has begun commercial shipments to Kenya of its new rapid HIV screening test, TrinScreen HIV.

Read more at globenewswire.com

Related news for (TRIB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.